Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.9 USD | -1.34% | -1.64% | -18.38% |
04-22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
03-28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.38% | 3.13B | |
+6.10% | 32.61B | |
+22.28% | 7.98B | |
+25.15% | 3.99B | |
-19.29% | 1.38B | |
-31.26% | 1.2B | |
+7.91% | 959M | |
-33.44% | 915M | |
-24.69% | 819M | |
-18.08% | 700M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- UBS Starts Evolent Health With Buy Rating, Price Target is $46